T. Rowe Price Associates’s Elanco Animal Health ELAN Stock Holding History

T. Rowe Price Associates’s Portfolio ELAN Stock Details ELAN Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$5.64M	Sell	395,198 -6,717	-2%	-$95.9K	﹤0.01%	1241
2025 Q1	$4.22M	Sell	401,915 -154,557	-28%	-$1.62M	﹤0.01%	1299
2024 Q4	$6.74M	Sell	556,472 -2,479,034	-82%	-$30M	﹤0.01%	1206
2024 Q3	$44.6M	Sell	3,035,506 -25,032,216	-89%	-$368M	0.01%	784
2024 Q2	$405M	Buy	28,067,722 +5,928,704	+27%	+$85.6M	0.05%	306
2024 Q1	$360M	Buy	22,139,018 +852,281	+4%	+$13.9M	0.04%	323
2023 Q4	$317M	Buy	21,286,737 +1,365,731	+7%	+$20.3M	0.04%	330
2023 Q3	$224M	Buy	19,921,006 +2,494,084	+14%	+$28M	0.03%	369
2023 Q2	$175M	Buy	17,426,922 +105,179	+0.6%	+$1.06M	0.02%	413
2023 Q1	$163M	Sell	17,321,743 -1,329,896	-7%	-$12.5M	0.02%	415
2022 Q4	$228M	Sell	18,651,639 -8,379,249	-31%	-$102M	0.04%	352
2022 Q3	$335M	Buy	27,030,888 +4,872,640	+22%	+$60.5M	0.06%	278
2022 Q2	$435M	Sell	22,158,248 -12,354,858	-36%	-$243M	0.06%	321
2022 Q1	$900M	Buy	34,513,106 +48,052	+0.1%	+$1.25M	0.09%	224
2021 Q4	$978M	Sell	34,465,054 -12,502,789	-27%	-$355M	0.09%	229
2021 Q3	$1.5B	Buy	46,967,843 +188,117	+0.4%	+$6M	0.14%	147
2021 Q2	$1.62B	Buy	46,779,726 +5,006,187	+12%	+$174M	0.15%	146
2021 Q1	$1.23B	Buy	41,773,539 +332,959	+0.8%	+$9.81M	0.12%	186
2020 Q4	$1.27B	Buy	41,440,580 +442,967	+1%	+$13.6M	0.13%	169
2020 Q3	$1.15B	Sell	40,997,613 -4,882,365	-11%	-$136M	0.13%	164
2020 Q2	$984M	Sell	45,879,978 -784,642	-2%	-$16.8M	0.12%	173
2020 Q1	$1.04B	Buy	46,664,620 +13,279,963	+40%	+$297M	0.17%	133
2019 Q4	$983M	Sell	33,384,657 -3,831,422	-10%	-$113M	0.13%	175
2019 Q3	$990M	Sell	37,216,079 -5,116,462	-12%	-$136M	0.14%	161
2019 Q2	$1.43B	Buy	42,332,541 +3,653,638	+9%	+$123M	0.2%	121
2019 Q1	$1.24B	Buy	38,678,903 +35,844,944	+1,265%	+$1.15B	0.18%	127
2018 Q4	$89.4M	Buy	2,833,959 +16,433	+0.6%	+$518K	0.02%	636
2018 Q3	$98.3M	Buy	+2,817,526	New	+$98.3M	0.01%	675